Study Guide and Note Outline for Oncologic Disorders

Study Guide and Note Outline for Oncologic Disorders

Study Guide and Note Outline for Oncologic Disorders

Covers assigned chapters in ATI and the Brunner & Suddarth text (see page and chart/table/figures to focus on below).

After reading the assigned chapters in the course textbook while using the ppts as study guides, consider focusing on the following. Note that these questions pertain to adult health in general and therefore are important irrespective of whether all of them/some of them appear on the exam!

ATI Chapters: 17 (bronchoscopy), 47 (colonoscopy, sigmoidoscopy, ostomy care), 62 (mammography), 89, 90, 91, 92, 93

General Cancer: Brunner and Suddarth, Chapter 15

Reading:

Entire chapter, excluding Hematopoietic Stem Cell Transplantation; Hyperthermia; Targeted Therapies; and Complementary, Alternative, and Integrative Health Therapies

Charts/Tables/Figures:

· Table 15-1, Characteristics of Benign and Malignant Tumors

· Chart 15-2, ACS Guidelines on Nutrition and Physical Activity for Cancer Prevention

· Table 15-3, AVS Screening Guidelines (breast, colorectal, and lung)

· Table 15-4 Selected Diagnostic Tests (breast, colorectal, lung)

· Chart 15-3, TNM Classification System

· Chart 15-5, Safety in Handling Chemo

· Chart 15-7, Plan of Nursing Care

· Table 15-13, Oncologic Emergencies for hypercalcemia, tumor lysis syndrome, superior vena cava syndrome

Learning Objective #1: Identify the epidemiology and etiology of cancer.

a. What are the top three cancers in men and women?

b. Compare the characteristics of malignant and benign cancer cells.

c. What are the broad categories of cancer-causing agents? Identify examples of each.

Learning Objective #2: Describe the health promotion, diagnosis, and spread of cancer.

a. Define primary, secondary, and tertiary prevention.

b. What are primary prevention recommendations for nutrition and physical activity?

c. What are the cancer screening recommendations for breast, colon, and lung cancer?

d. How is the TNM staging and grading system interpreted?

e. What is metastasis and how does it primarily occur?

 

 

 

Learning Objective #3: Describe the management of patients undergoing of surgery for cancer treatment.

a. What are the types of surgeries in cancer treatment and the goal of each?

b. What are the post-operative concerns, regardless of type?

Learning Objective #4: Describe the management of patients undergoing radiation.

a. What is the difference between external and internal radiation?

b. When do localized, early systemic, and late/chronic systemic effects occur and usually resolve?

c. What are common systemic effects (early and late/chronic) of radiation therapy?

d. What are the most common localized effects, depending on the area of radiation?

e. How do healthcare workers and caregivers protect themselves from the effects of internal radiation therapy?

Learning Objective #5: Describe the management of patients undergoing of chemotherapy.

c. What are the routes of chemotherapy administration and most common side effects?

d. What are the precautions a healthcare worker should take when caring for a patient receiving chemotherapy?

e. Describe the prevention, signs/symptoms, and interventions for chemotherapy extravasation.

f. Describe the types, timing, desensitization procedures, and priority intervention for hypersensitivity reactions.

Learning Objective #6: Identify assessment and nursing management of patients with cancer and with oncologic emergencies.

a. What are the nursing interventions and rationales for patients with the following nursing diagnoses:

i. Risk for infection r/t myelosuppression

ii. Risk for impaired skin integrity: erythematous and wet desquamation reactions to radiation therapy

iii. Impaired oral mucous membrane r/t stomatitis

iv. Imbalanced nutrition r/t nausea and vomiting

v. Imbalanced nutrition r/t anorexia or malabsorption

vi. Risk for bleeding

b. Explain the patho/causes, signs/symptoms, and interventions for hypercalcemia, tumor lysis syndrome, and superior vena cava syndrome.